Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
NT-0796
Cat. No.:
OB0425LY-204
Appearance:
Solid
Purity:
99.65%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
NT-0796 is a special CNS-penetrant NLRP3 inflammasome inhibitor that inhibits IL-1β release in human PBMC cells.
Synonyms:
NT0796; 2272917-13-0; Propan-2-yl (2R)-2-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyloxy)-3-pyrimidin-2-ylpropanoate; Isopropyl (R)-2-(((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)oxy)-3-(pyrimidin-2-yl)propanoate
CAS No.:
2272917-13-0
Compound CID:
152031485
Formula:
C23H27N3O4
Formula Weight:
409.49
Specification
Target:
NOD-like receptor (NLR); Interleukin related
Pathway:
Immunology/Inflammation
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
NT-0796 can be used in obesity science research to explore its potential application in metabolic diseases or psychiatric disorders.
